309 related articles for article (PubMed ID: 6805532)
1. Multimeric composition of factor VIII/von Willebrand factor following administration of DDAVP: implications for pathophysiology and therapy of von Willebrand's disease subtypes.
Ruggeri ZM; Mannucci PM; Lombardi R; Federici AB; Zimmerman TS
Blood; 1982 Jun; 59(6):1272-8. PubMed ID: 6805532
[TBL] [Abstract][Full Text] [Related]
2. Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets.
Ruggeri ZM; Zimmerman TS
J Clin Invest; 1980 Jun; 65(6):1318-25. PubMed ID: 6773982
[TBL] [Abstract][Full Text] [Related]
3. Platelet aggregation induced by 1-desamino-8-D-arginine vasopressin (DDAVP) in Type IIB von Willebrand's disease.
Holmberg L; Nilsson IM; Borge L; Gunnarsson M; Sjörin E
N Engl J Med; 1983 Oct; 309(14):816-21. PubMed ID: 6412139
[TBL] [Abstract][Full Text] [Related]
4. Type IIB von Willebrand's disease: differential clearance of endogenous versus transfused large multimer von willebrand factor.
Ruggeri ZM; Lombardi R; Gatti L; Bader R; Valsecchi C; Zimmerman TS
Blood; 1982 Dec; 60(6):1453-6. PubMed ID: 6982737
[TBL] [Abstract][Full Text] [Related]
5. Response of factor VIII/von Willebrand factor to DDAVP in healthy subjects and patients with haemophilia A and von Willebrand's disease.
Mannucci PM; Canciani MT; Rota L; Donovan BS
Br J Haematol; 1981 Feb; 47(2):283-93. PubMed ID: 6781527
[TBL] [Abstract][Full Text] [Related]
6. DDAVP in type IIa von Willebrand's disease.
Gralnick HR; Williams SB; McKeown LP; Rick ME; Maisonneuve P; Jenneau C; Sultan Y
Blood; 1986 Feb; 67(2):465-8. PubMed ID: 3080040
[TBL] [Abstract][Full Text] [Related]
7. DDAVP: a useful alternative to blood components in moderate hemophilia A and von Willebrand disease.
Warrier AI; Lusher JM
J Pediatr; 1983 Feb; 102(2):228-33. PubMed ID: 6401806
[TBL] [Abstract][Full Text] [Related]
8. Studies on the pathophysiology and treatment of von Willebrand's disease. V. Properties of factor VIII after DDAVP infusion in variant von Willebrand's disease.
Takahashi H
Thromb Res; 1981 Feb 15-Mar 1; 21(4-5):357-65. PubMed ID: 6791293
[No Abstract] [Full Text] [Related]
9. Demonstration of abnormal factor VIII multimers in acquired von Willebrand's disease associated with a circulating inhibitor.
Ball J; Malia RG; Greaves M; Preston FE
Br J Haematol; 1987 Jan; 65(1):95-100. PubMed ID: 3101732
[TBL] [Abstract][Full Text] [Related]
10. Von Willebrand factor multimer patterns in von Willebrand's disease.
Hoyer LW; Rizza CR; Tuddenham EG; Carta CA; Armitage H; Rotblat F
Br J Haematol; 1983 Nov; 55(3):493-507. PubMed ID: 6416288
[TBL] [Abstract][Full Text] [Related]
11. Re-evaluation of the therapeutic efficacy of DDAVP in type IIB von Willebrand's disease.
Casonato A; Pontara E; Dannhaeuser D; Bertomoro A; Sartori MT; Zerbinati P; Girolami A
Blood Coagul Fibrinolysis; 1994 Dec; 5(6):959-64. PubMed ID: 7893933
[TBL] [Abstract][Full Text] [Related]
12. Response to desmopressin in type IID von Willebrand's disease.
Thomas N; O'Callaghan U; Lowe GD; Olszynski V; Kernoff PB; Abildgaard CF; Tuddenham EG
Clin Lab Haematol; 1989; 11(3):189-97. PubMed ID: 2591151
[TBL] [Abstract][Full Text] [Related]
13. Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.
Michiels JJ; van de Velde A; van Vliet HH; van der Planken M; Schroyens W; Berneman Z
Semin Thromb Hemost; 2002 Apr; 28(2):111-32. PubMed ID: 11992235
[TBL] [Abstract][Full Text] [Related]
14. Intranasal desmopressin (DDAVP) by spray in mild hemophilia A and von Willebrand's disease type I.
Lethagen S; Harris AS; Nilsson IM
Blut; 1990 Mar; 60(3):187-91. PubMed ID: 2107887
[TBL] [Abstract][Full Text] [Related]
15. von Willebrand's disease: use of collagen binding assay provides potential improvement to laboratory monitoring of desmopressin (DDAVP) therapy.
Favaloro EJ; Dean M; Grispo L; Exner T; Koutts J
Am J Hematol; 1994 Mar; 45(3):205-11. PubMed ID: 8296790
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneous abnormalities in the multimeric structure, antigenic properties, and plasma-platelet content of factor VIII/von Willebrand factor in subtypes of classic (type I) and variant (type IIA) von Willebrand's disease.
Weiss HJ; Pietu G; Rabinowitz R; Girma JP; Rogers J; Meyer D
J Lab Clin Med; 1983 Mar; 101(3):411-25. PubMed ID: 6186757
[TBL] [Abstract][Full Text] [Related]
17. DDAVP enhances platelet adherence and platelet aggregate growth on human artery subendothelium.
Sakariassen KS; Cattaneo M; vd Berg A; Ruggeri ZM; Mannucci PM; Sixma JJ
Blood; 1984 Jul; 64(1):229-36. PubMed ID: 6428488
[TBL] [Abstract][Full Text] [Related]
18. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
CMAJ; 1995 Jul; 153(2):147-57. PubMed ID: 7600466
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and management of von Willebrand's syndrome.
Rick ME
Med Clin North Am; 1994 May; 78(3):609-23. PubMed ID: 8170261
[TBL] [Abstract][Full Text] [Related]
20. A probable double heterozygous type II von Willebrand's disease with increased ristocetin induced platelet aggregation.
Kinoshita S; Yoshioka K; Kasahara M; Takamiya O
Am J Hematol; 1992 Jul; 40(3):192-8. PubMed ID: 1609773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
